What is it?
Cognitive benefit has not been established
1A 2023 systematic review of randomized trials in postmenopausal women found no evidence that DHEA improves cognitive performance.
A year-long trial found no broad benefit
3In the DAWN trial, 50 mg/day of DHEA for one year did not improve cognitive function, quality-of-life measures, depression scores, or sexual-function scales compared with placebo in healthy older adults. This study dose is research context, not a consumer dosage recommendation.
Names, aliases and forms
Mechanisms of action
Hormone precursor, not a standard nootropic mechanism
8DHEA is a steroid hormone that the body can convert into testosterone, androstenedione, and estradiol. That hormone-conversion pathway does not demonstrate a cognition benefit.
Potential effects and evidence map
Grade D for cognitive or performance use: randomized studies and systematic reviews in healthy older or postmenopausal adults do not establish a reliable benefit. DHEA can convert to sex hormones, and safety for self-directed use has not been adequately assessed.
Evidence does not establish a reliable memory or learning benefit in the studied postmenopausal population.
Safety, side effects and risk profile
DHEA can be converted to sex hormones. The NIH ODS summary says its safety has not been adequately assessed; studies in women taking it for a few months reported increased testosterone, acne, and facial-hair growth.
For athletes subject to applicable anti-doping rules, WADA lists prasterone/dehydroepiandrosterone/DHEA under anabolic androgenic steroids in the 2026 Prohibited List.
For cognitive or performance use, reliable benefit is not established and the NIH ODS summary says safety has not been adequately assessed.
The NIH ODS summary describes acne and facial-hair growth in women who took DHEA for a few months, alongside increased testosterone in those studies.
Interactions and cautions
The sources used for this profile do not establish a comprehensive medication-interaction list. Because DHEA can change sex-hormone exposure, people using prescribed hormone-related care should have the exact product reviewed by a clinician or pharmacist rather than relying on a generic list.
Legal and regulatory status
In the U.S., FDA does not approve dietary supplements or their product labels before sale. FDA also says a product sold as a dietary supplement may not make a disease claim. This is U.S. regulatory context as checked in August 2026, not a legal-status statement elsewhere.
For athletes in the United States and elsewhere who are subject to World Anti-Doping Agency rules, the 2026 Prohibited List, effective 1 January 2026, places prasterone/dehydroepiandrosterone/DHEA under anabolic androgenic steroids. This is a sport-rule restriction, not a general legal-status statement.
How it compares
DHEA changes hormone exposure and has not shown a reliable cognitive benefit in the studied populations. The relevant comparison is product form and stated strength after the hormone context has been assessed, not package price alone.
Practical buying and quality notes
- The current catalog has 22 active listings across 2 vendors: 14 loose powders and 8 capsules or tablets. Eight entries have 2021 crawl dates and multiple listings have no normalized serving dose, so the data cannot establish a universal current per-dose comparison.10
- Loose-powder package weight and capsule or tablet count are not interchangeable measures. Some 50 mg and 100 mg capsule rows are repeat crawls, so do not count them as independent product evidence when comparing form or price.10
- A listing without a normalized serving amount cannot support a per-dose comparison. The catalog also includes eight entries with 2021 crawl dates, whose presence must not be read as current availability or current price.10
FAQ
Does research establish a self-directed DHEA dose?
3No. A 50 mg/day dose was used in the DAWN trial, but it did not improve cognitive or quality-of-life outcomes. Do not convert this research detail into a general dose recommendation.
Who needs sport-rule screening?
6Athletes subject to WADA or another anti-doping program need to check the applicable rules before use. WADA's 2026 list identifies DHEA and its named synonyms as prohibited anabolic androgenic steroids.
What should a product comparison disclose?
10Use product form, the stated serving amount, and listing freshness when those fields exist. Do not infer a comparable daily cost from package weight when the serving amount is absent.
References
- Sultana F, Davis SR, Islam RM. Effect of dehydroepiandrosterone therapy on cognitive performance among postmenopausal women: a systematic review of randomized clinical trial data. Menopause. 2023.
- Grimley Evans J, Malouf R, Huppert F, van Niekerk JK. Dehydroepiandrosterone (DHEA) supplementation for cognitive function in healthy elderly people. Cochrane Database Syst Rev. 2006.
- Kritz-Silverstein D, von Muhlen D, Laughlin GA, Bettencourt R. Effects of dehydroepiandrosterone supplementation on cognitive function and quality of life: the DHEA and Well-Ness (DAWN) Trial. J Am Geriatr Soc. 2008.
- Elraiyah T, Sonbol MB, Wang Z, et al. The benefits and harms of systemic dehydroepiandrosterone in postmenopausal women with normal adrenal function: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2014.
- Peixoto C, Carrilho CG, Barros JA, et al. The effects of dehydroepiandrosterone on sexual function: a systematic review. Climacteric. 2017.
- World Anti-Doping Agency. The 2026 Prohibited List, effective 1 January 2026.
- U.S. FDA. Information for Consumers on Using Dietary Supplements.
- NIH Office of Dietary Supplements. Dietary Supplements for Exercise and Athletic Performance: Health Professional Fact Sheet. Accessed August 2026.
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements. Accessed August 2026.
- NootropicsIndex product catalog snapshot for DHEA, queried 1 August 2026.